United States (US) Rare Disease Genetic Testing Market (2025-2031) | Growth, Trends, Competitive Landscape, Analysis, Value, Segmentation, Size & Revenue, Outlook, Companies, Industry, Share, Forecast

Market Forecast By Disease Type (Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disease), By Technology (Next Generation Sequencing, Whole Exome Sequencing, Whole Genome Sequencing, Array Technology, PCR-based Testing, FISH, Sanger Sequencing, Karyotyping), By Specialty (Molecular Genetic Tests, Chromosomal Genetic Tests, Biochemical Genetic Tests), By End use (Research Laboratories & CROs, Hospitals & Clinics, Diagnostic Laboratories) And Competitive Landscape
Product Code: ETC9974984 Publication Date: Sep 2024 Updated Date: Jan 2025 Product Type: Market Research Report
Publisher: 6Wresearch No. of Pages: 75 No. of Figures: 35 No. of Tables: 20

Key Highlights of the Report:

  • United States (US) Rare Disease Genetic Testing Market Outlook
  • Market Size of United States (US) Rare Disease Genetic Testing Market, 2024
  • Forecast of United States (US) Rare Disease Genetic Testing Market, 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Revenues & Volume for the Period 2021- 2031
  • United States (US) Rare Disease Genetic Testing Market Trend Evolution
  • United States (US) Rare Disease Genetic Testing Market Drivers and Challenges
  • United States (US) Rare Disease Genetic Testing Price Trends
  • United States (US) Rare Disease Genetic Testing Porter's Five Forces
  • United States (US) Rare Disease Genetic Testing Industry Life Cycle
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Disease Type for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Neurological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Immunological Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Hematology Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Endocrine & Metabolism Diseases for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Cancer for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Musculoskeletal Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Cardiovascular Disorders for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Neurological Disorders Rare Disease Genetic Testing Market Revenues & Volume By Dermatology Disease for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Technology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Next Generation Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Whole Exome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Whole Genome Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Array Technology for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By PCR-based Testing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By FISH for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Sanger Sequencing for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Karyotyping for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Specialty for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Molecular Genetic Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Chromosomal Genetic Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Biochemical Genetic Tests for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By End use for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Research Laboratories & CROs for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Hospitals & Clinics for the Period 2021- 2031
  • Historical Data and Forecast of United States (US) Rare Disease Genetic Testing Market Revenues & Volume By Diagnostic Laboratories for the Period 2021- 2031
  • United States (US) Rare Disease Genetic Testing Import Export Trade Statistics
  • Market Opportunity Assessment By Disease Type
  • Market Opportunity Assessment By Technology
  • Market Opportunity Assessment By Specialty
  • Market Opportunity Assessment By End use
  • United States (US) Rare Disease Genetic Testing Top Companies Market Share
  • United States (US) Rare Disease Genetic Testing Competitive Benchmarking By Technical and Operational Parameters
  • United States (US) Rare Disease Genetic Testing Company Profiles
  • United States (US) Rare Disease Genetic Testing Key Strategic Recommendations

Frequently Asked Questions About the Market Study (FAQs):

6W monitors the market across 60+ countries Globally, publishing an annual market outlook report that analyses trends, key drivers, Size, Volume, Revenue, opportunities, and market segments. This report offers comprehensive insights, helping businesses understand market dynamics and make informed decisions.
Yes, we provide customisation as per your requirements. To learn more, feel free to contact us on sales@6wresearch.com

1 Executive Summary

2 Introduction

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3 United States (US) Rare Disease Genetic Testing Market Overview

3.1 United States (US) Country Macro Economic Indicators

3.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, 2021 & 2031F

3.3 United States (US) Rare Disease Genetic Testing Market - Industry Life Cycle

3.4 United States (US) Rare Disease Genetic Testing Market - Porter's Five Forces

3.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F

3.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By Specialty, 2021 & 2031F

3.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume Share, By End use, 2021 & 2031F

4 United States (US) Rare Disease Genetic Testing Market Dynamics

4.1 Impact Analysis

4.2 Market Drivers

4.3 Market Restraints

5 United States (US) Rare Disease Genetic Testing Market Trends

6 United States (US) Rare Disease Genetic Testing Market, By Types

6.1 United States (US) Rare Disease Genetic Testing Market, By Disease Type

6.1.1 Overview and Analysis

6.1.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Disease Type, 2021- 2031F

6.1.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Neurological Disorders, 2021- 2031F

6.1.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Immunological Disorders, 2021- 2031F

6.1.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Hematology Diseases, 2021- 2031F

6.1.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Endocrine & Metabolism Diseases, 2021- 2031F

6.1.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Cancer, 2021- 2031F

6.1.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Musculoskeletal Disorders, 2021- 2031F

6.1.9 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F

6.1.10 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Dermatology Disease, 2021- 2031F

6.2 United States (US) Rare Disease Genetic Testing Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Next Generation Sequencing, 2021- 2031F

6.2.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F

6.2.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F

6.2.5 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Array Technology, 2021- 2031F

6.2.6 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By PCR-based Testing, 2021- 2031F

6.2.7 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By FISH, 2021- 2031F

6.2.8 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F

6.2.9 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Karyotyping, 2021- 2031F

6.3 United States (US) Rare Disease Genetic Testing Market, By Specialty

6.3.1 Overview and Analysis

6.3.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Molecular Genetic Tests, 2021- 2031F

6.3.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Chromosomal Genetic Tests, 2021- 2031F

6.3.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Biochemical Genetic Tests, 2021- 2031F

6.4 United States (US) Rare Disease Genetic Testing Market, By End use

6.4.1 Overview and Analysis

6.4.2 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Research Laboratories & CROs, 2021- 2031F

6.4.3 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Hospitals & Clinics, 2021- 2031F

6.4.4 United States (US) Rare Disease Genetic Testing Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F

7 United States (US) Rare Disease Genetic Testing Market Import-Export Trade Statistics

7.1 United States (US) Rare Disease Genetic Testing Market Export to Major Countries

7.2 United States (US) Rare Disease Genetic Testing Market Imports from Major Countries

8 United States (US) Rare Disease Genetic Testing Market Key Performance Indicators

9 United States (US) Rare Disease Genetic Testing Market - Opportunity Assessment

9.1 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F

9.2 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By Specialty, 2021 & 2031F

9.4 United States (US) Rare Disease Genetic Testing Market Opportunity Assessment, By End use, 2021 & 2031F

10 United States (US) Rare Disease Genetic Testing Market - Competitive Landscape

10.1 United States (US) Rare Disease Genetic Testing Market Revenue Share, By Companies, 2024

10.2 United States (US) Rare Disease Genetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters

11 Company Profiles

12 Recommendations

13 Disclaimer

Pricing
  • Single User License
    $ 1,995
  • Department License
    $ 2,400
  • Site License
    $ 3,120
  • Global License
    $ 3,795
6Wresearch Support

Any Query

Call: +91-11-4302-4305
Email us: sales@6wresearch.com
Any Query? Click Here

Industry Events and Analyst Meet

Our Clients

Airtel
Canon
Contec
HoneyWell
Kriloskar
Pwc Logo
Samsung
Tata Teleservices

Whitepaper

Read All